A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: The tRNA-derived small RNAs (tsRNAs) are produced in a nuclease-dependent manner in responses to variety of stresses that are common in cancers. We focus on a cancer-enriched tsRNA signature to develop a salivary exosome-based non-invasive biomarker for human esophageal squamous cell carcinoma (ESCC). Methods: Cancer-enriched small RNAs were identified by RNA sequencing of salivary exosomes obtained from ESCC patients (n = 3) and healthy controls (n = 3) in a pilot study and further validated in discovery cohort (n = 66). A multicenter prospective observational study was conducted in two ESCC high-incidence regions (n = 320 and 200, respectively) using the newly developed biomarker signature. Results: The tsRNA (tRNA-GlyGCC-5) and a previously undocumented small RNA were specifically enriched in salivary exosomes of ESCC patients, ESCC tissues and ESCC cells. The bi-signature composed of these small RNAs was able to discriminate ESCC patients from the controls with high sensitivity (90.50%) and specificity (94.20%). Based on the bi-signature Risk Score for Prognosis (RSP), patients with high-RSP have both shorter overall survival (OS) (HR 4.95, 95%CI 2.90–8.46) and progression-free survival (PFS) (HR 3.69, 95%CI 2.24–6.10) than those with low-RSP. In addition, adjuvant therapy improved OS (HR 0.47, 95%CI 0.29–0.77) and PFS (HR 0.36, 95%CI 0.21–0.62) only for patients with high but not low RSP. These findings are consistent in both training and validation cohort. Conclusions: The tsRNA-based signature not only has the potential for diagnosis and prognosis but also may serve as a pre-operative biomarker to select patients who would benefit from adjuvant therapy. Trial registration: A prospective study of diagnosis biomarkers of esophageal squamous cell carcinoma, ChiCTR2000031507. Registered 3 April 2016 - Retrospectively registered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
tRNA-derived small RNAs target transposable element transcripts
Martinez, G., Choudury, S. G., & Slotkin, R. K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx103 · Cited by 274
Research works printed but not linked: 42
- Pennathur A, Gibson MK, Jobe BA, et al. Esophageal carcinoma. Lancet. 2013;381(9864):400–12. · DOI · Paper page
- Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52. · DOI · Paper page
- Du L, Wang L, Gan J, et al. MTA3 represses Cancer Stemness by targeting the SOX2OT/SOX2 Axis. iScience. 2019;22:353–68. · DOI
- Pouliquen X, Levard H, Hay JM, et al. 5-fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French associations for surgical research. Ann Surg. 1996;223(2):127–33. · doi:10.1097/00000658-199602000-00003
- Ando N, Iizuka T, Kakegawa T, et al. A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan clinical oncology group study. J Thorac Cardiovasc Surg. 1997;114(2):205–9. · DOI
- Ando N, Iizuka T, Ide H, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. J Clin Oncol. 2003;21(24):4592–6. · DOI · Paper page
- Vaidyanathan R, Soon RH, Zhang P, et al. Cancer diagnosis: from tumor to liquid biopsy and beyond. Lab Chip. 2018;19(1):11–34.
- Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–90. · DOI · Paper page
- De Rubis G, Rajeev Krishnan S, Bebawy M. Liquid biopsies in Cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci. 2019;40(3):172–86. · DOI · Paper page
- Sharma S, Zhuang R, Long M, et al. Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018;36(4):1063–78. · DOI · Paper page
- Li F, Kaczor-Urbanowicz KE, Sun J, et al. Characterization of human salivary extracellular RNA by next-generation sequencing. Clin Chem. 2018;64(7):1085–95. · DOI
- Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res. 2012;40(21):10937–49. · DOI · Paper page
- Jia S, Zhang Q, Wang Y, et al. PIWI-interacting RNA sequencing profiles in maternal plasma-derived exosomes reveal novel non-invasive prenatal biomarkers for the early diagnosis of nonsyndromic cleft lip and palate. EBioMedicine. 2021;65:103253.
- Zhu L, Li J, Gong Y, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019;18(1):74. · DOI · Paper page
- LeBleu VS, Kalluri R. Exosomes as a multicomponent biomarker platform in Cancer. Trends Cancer. 2020;6(9):767–74. · DOI · Paper page
- Cole C, Sobala A, Lu C, et al. Filtering of deep sequencing data reveals the existence of abundant dicer-dependent small RNAs derived from tRNAs. RNA. 2009;15(12):2147–60. · DOI · Paper page
- Yamasaki S, Ivanov P, Hu GF, et al. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J Cell Biol. 2009;185(1):35–42. · DOI · Paper page
- Thompson DM, Lu C, Green PJ, et al. tRNA cleavage is a conserved response to oxidative stress in eukaryotes. RNA. 2008;14(10):2095–103. · DOI · Paper page
- Thompson DM, Parker R. Stressing out over tRNA cleavage. Cell. 2009;138(2):215–9. · DOI · Paper page
- Ivanov P, Emara MM, Villen J, et al. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 2011;43(4):613–23. · DOI · Paper page
- Couvillion MT, Bounova G, Purdom E, et al. A Tetrahymena Piwi bound to mature tRNA 3′ fragments activates the exonuclease Xrn2 for RNA processing in the nucleus. Mol Cell. 2012;48(4):509–20. · DOI · Paper page
- Zong T, Yang Y, Zhao H, et al. tsRNAs: novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif. 2021;54(3):e12977. · DOI
- Lin Y, Dong H, Deng W, et al. Evaluation of salivary Exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin Cancer Res. 2019;25(10):3035–45. · DOI
- Yu J, Lin Y, Xiong X, et al. Detection of Exosomal PD-L1 RNA in saliva of patients with periodontitis. Front Genet. 2019;10:202. · DOI
- Ke X, Xiong X, Lin Y, et al. Chimeric RNA and Exosomes-based liquid biopsy. Methods Mol Biol. 2020;2079:211–8. · DOI
- Chan AC, Fan ST, Poon RT, et al. Evaluation of the seventh edition of the American joint committee on Cancer tumor-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system. HPB (Oxford). 2013;15(6):439–48. · DOI
- Wang S, Lin Y, Xiong X, et al. Low-dose metformin reprograms the tumor immune microenvironment in human esophageal Cancer: results of a phase II clinical trial. Clin Cancer Res. 2020;26(18):4921–32. · DOI · Paper page
- Xiong X, Ke X, Wang L, et al. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target. Proc Natl Acad Sci U S A. 2020;117(12):6726–32. · DOI
- Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188–95. · DOI · Paper page
- Jima DD, Zhang J, Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116(23):e118–27. · DOI · Paper page
- Fang S, He T, Jiang J, et al. Osteogenic effect of tsRNA-10277-loaded exosome derived from bone Mesenchymal stem cells on steroid-induced osteonecrosis of the femoral head. Drug Des Devel Ther. 2020;14:4579–91. · DOI
- Meng L, Jiang L, Chen J, et al. Transfer RNA-derived fragment tRF-28-QSZ34KRQ590K in plasma exosomes may be a potential biomarker for atopic dermatitis in pediatric patients. Exp Ther Med. 2021;21(5):489. · DOI
- Wang J, Ma G, Li M, et al. Plasma tRNA fragments derived from 5′ ends as novel diagnostic biomarkers for early-stage breast Cancer. Mol Ther Nucleic Acids. 2020;21:954–64. · DOI
- Wang W, He X, Zheng Z, et al. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma. Mol Cancer. 2017;16(1):75. · DOI
- Zheng X, Xing S, Liu XM, et al. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma. BMC Cancer. 2014;14:490. · doi:10.1186/1471-2407-14-490
- Wang W, Chen D, Zhao Y, et al. Characterization of LAG-3, CTLA-4, and CD8(+) TIL density and their joint influence on the prognosis of patients with esophageal squamous cell carcinoma. Ann Transl Med. 2019;7(23):776. · DOI
- Cui Y, Chen H, Xi R, et al. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020;30(10):902–13. · DOI · Paper page
- Al Kawas S, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol. 2012;57(1):1–9. · DOI
- Wong DT. Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn. 2006;6(3):267–72. · DOI
- Ogawa Y, Taketomi Y, Murakami M, et al. Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing. Biol Pharm Bull. 2013;36(1):66–75. · DOI · Paper page
- Chang SL, Lee SW, Yang SF, et al. Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma. APMIS. 2020;128(4):287–97. · DOI
- Li P, Lin Y, Zhang Y, et al. SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med. 2013;11:52. · DOI
Cited by
Clinical application and detection techniques of liquid biopsy in gastric cancer
Ma, S., Zhou, M., Xu, Y., Gu, X., Zou, M., Abudushalamu, G., Yao, Y., Fan, X., & Wu, G. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01715-z · Cited by 190
“[229] found that using tRNAGlyGCC-5 and sRESE alone has a much lower effect on identifying esophageal squamous cell carcinoma than using both.”
MethodExtracellular vesicles as personalized medicine
Beetler, D. J., Di Florio, D. N., Bruno, K. A., Ikezu, T., March, K. L., Cooper, L. T., Wolfram, J., & Fairweather, D. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101155 · Cited by 101
Chen, Y., Fang, H., Chen, H., Liu, X., Zhao, J., Stanton, C., Ross, R. P., Chen, W., & Yang, B. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2464945 · Cited by 44
Self-citationNetwork approach in liquidomics landscape
Santini, D., Botticelli, A., Galvano, A., Iuliani, M., Incorvaia, L., Gristina, V., Taffon, C., Foderaro, S., Paccagnella, E., Simonetti, S., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02743-9 · Cited by 37
Metadata
- Authors
- Li, K., Lin, Y., Luo, Y., Xiong, X., Wang, L., Durante, K., Li, J., Zhou, F., Guo, Y., Chen, S., Chen, Y., Zhang, D., Yeung, S.-C. J., & Zhang, H.
- Venue
- Molecular Cancer
- Published
- 2022-01-18
- Volume
- 21
- Issue
- 1
- Pages
- 21-21
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W4205681991
- Cited by
- 183
- References
- 4
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- National Natural Science Foundation of China (82072683, 81773087, 81071736, 81572876, 30973508)
- Natural Science Foundation of Guangdong Province (2021A1515012522, 9151018004000000)
- Science and Technology Planning Project of Guangdong Province (2019A030317024)
- Special Project on the Integration of Industry, Education and Research of Guangdong Province (2011A090100024)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. https://app.cochat.ai/papers/10.1186/s12943-022-01499-8
- The paper
- Li, K., Lin, Y., Luo, Y., Xiong, X., Wang, L., Durante, K., Li, J., Zhou, F., Guo, Y., Chen, S., Chen, Y., Zhang, D., Yeung, S.-C. J., & Zhang, H. (2022). A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Molecular Cancer. https://doi.org/10.1186/s12943-022-01499-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.